Build the case for broader patient coverage
PRO connects patient access experience with payer policy strategy to support coverage expansion.
We help your team prioritize opportunities and plan an approach to policy expansion.
Patient-Level Insights. Policy-Level Strategy.
Every coverage request offers insight into how a payer evaluates your product. PRO brings those insights into your market access strategy, connecting patterns in case decisions with opportunities for policy change.
We combine documented treatment demand, provider perspectives, and clinical evidence to make the case for broader coverage, helping your team prioritize policy efforts that support product uptake.
Payer insights that inform your coverage strategy
Understanding how payers evaluate your product helps your team plan its next steps. PRO draws on patient access experience and published information to identify coverage patterns and inform policy strategy. Providers retain responsibility for clinical judgment, patient-specific medical necessity documentation, and their communications with payers.
A focused plan for your stage of commercialization
Before launch, we help you consider payer expectations alongside your evidence and access plans. For products already in market, we use case experience to inform coverage priorities. Payer Solutions can operate alongside your existing patient services team or as part of a PRO program.
PRO-spectives
Building Your Path to Digital Therapeutics Coverage
A practical guide for digital therapeutics manufacturers preparing for payor review: why early cases stall and how to build a coverage path case by case.
Read Article
Patient Access, Built Around Every Patient and Every Case
When should we begin payer policy planning?
Begin during clinical development, while endpoints and comparators are being considered. Early planning helps align evidence with questions payers may ask about the product’s value relative to current care.
What types of products does PRO support?
Our approach applies across pharmaceuticals, medical devices, diagnostics, and digital therapeutics, with particular relevance for products covered under the medical benefit. Each strategy is unique based on each product’s evidence and coverage pathway.
How does patient services experience inform payer strategy?
Patterns in coverage requests and appeal outcomes show how payers apply existing criteria and consider medical necessity. We use that information to identify priorities for provider-led policy discussions and additional evidence collection.
